StockData
MHUAFOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Meihua International Medical Technologies Co., Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$6.50+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
0.4
Dividend yield
–

Meihua International Medical Technologies statistics

Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison

Valuation

MeasureMeihua International Medical TechnologiesIndustry median
Market Cap$4.54M$230.55M
Enterprise Value-$1.63M$202.97M
PE Ratio0.3633.40
PS Ratio0.073.11
PB Ratio0.023.14
P/TBV Ratio0.024.57
P/FCF Ratio8.1827.25
P/OCF Ratio7.9622.35

Enterprise value

MeasureMeihua International Medical TechnologiesIndustry median
EV / Sales-0.032.92
EV / EBITDA-0.2019.86
EV / EBIT-0.2024.88
EV / FCF-2.9427.85

Income (trailing twelve months)

MeasureMeihua International Medical TechnologiesIndustry median
Revenue$61.79M$102.39M
Gross Profit$19.16M$60.36M
Operating Income$8.28M-$4.31M
Pretax Income$9.41M-$2.26M
Net Income$6.78M-$6.57M
EBITDA$8.28M-$1.98M
EPS (Diluted)$18.04-$0.07

Margins

MeasureMeihua International Medical TechnologiesIndustry median
Gross Margin31.0%55.1%
Operating Margin13.4%-6.04%
Pretax Margin15.2%-4.11%
Profit Margin11.0%-10.5%
EBITDA Margin13.4%-2.67%
FCF Margin0.90%-0.30%

Returns

MeasureMeihua International Medical TechnologiesIndustry median
Return on Equity (ROE)3.90%-19.2%
Return on Assets (ROA)3.45%-13.3%
Return on Invested Capital (ROIC)3.58%-4.11%
Return on Capital Employed (ROCE)4.38%-9.07%

Growth

MeasureMeihua International Medical TechnologiesIndustry median
Revenue Growth (YoY)-36.2%8.85%
Net Income Growth (YoY)-37.5%10.6%
EPS Growth (YoY)-54.5%10.6%
FCF Growth (YoY)-96.2%10.6%
Revenue Growth (3Y CAGR)-15.8%7.08%
Revenue Growth (5Y CAGR)-7.05%11.8%
EPS Growth (3Y CAGR)-12.6%3.06%
EPS Growth (5Y CAGR)-28.3%7.64%

Balance sheet

MeasureMeihua International Medical TechnologiesIndustry median
Cash & Short-Term Investments$15.15M$37.33M
Total Debt$8.99M$72.66M
Net Cash (Debt)$6.17M$3.92M
Net Cash Per Share$8.84$0.28
Equity (Book Value)$188.93M$57.36M
Book Value Per Share$270.71$2.81
Tangible Book Value$188.49M$10.71M
Working Capital$135.33M$54.64M

Financial position

MeasureMeihua International Medical TechnologiesIndustry median
Current Ratio8.422.50
Quick Ratio5.451.54
Debt / Equity0.050.38
Debt / EBITDA1.082.31
Debt / FCF16.223.50
Net Debt / EBITDA-0.741.53
Interest Coverage34.30-1.81

Cash flow (trailing twelve months)

MeasureMeihua International Medical TechnologiesIndustry median
Operating Cash Flow$569.88K-$653.46K
Capital Expenditures-$15.63K-$3.69M
Free Cash Flow$554.25K-$835.02K
FCF Per Share$0.79-$0.02

Efficiency

MeasureMeihua International Medical TechnologiesIndustry median
Asset Turnover0.310.59
Inventory Turnover27.382.21
Revenue Per Employee$895.54K$322.57K
Profits Per Employee$98.29K-$51.88K
Employee Count69185

Dividends and yields

MeasureMeihua International Medical TechnologiesIndustry median
Earnings Yield149.5%-6.91%
FCF Yield12.2%-0.56%

Shares

MeasureMeihua International Medical TechnologiesIndustry median
Shares Outstanding697,91444,856,700
Shares Change (YoY)37.4%3.35%
Float697,91437,097,900
Shares Held by Insiders0.00%10.6%

Taxes

MeasureMeihua International Medical TechnologiesIndustry median
Income Tax$2.62M$1.52M
Effective Tax Rate27.9%18.6%

Scores

MeasureMeihua International Medical TechnologiesIndustry median
Graham Number$331.48$34.37
Graham Upside4999.7%-57.7%
Altman Z-Score2.121.95
Piotroski F-Score45

Calculated by StockData from Meihua International Medical Technologies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.